SAN FRANCISCO, January 3, 2017 /PRNewswire/ --
The global drug and gene delivery systems market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.
Browse full research report with TOC on "Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Gene Delivery Type (In situ, Ex vivo), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market
Further key findings from the study suggest:
- The market study suggests that oral segment dominated the market in 2015
- The convenience of use and low manufacturing cost are the prime factors responsible for the dominance of the oral delivery segment
- Injectable segment is expected to show a lucrative growth rate owing to the introduction of technically advanced injecting devices that enable convenient self-injection
- North America dominated the market in 2015 and is expected to remain dominant throughout the forecast period owing to highly developed healthcare infrastructure and high healthcare spending
- Asia pacific is expected to exhibit the fastest growth rate during the forecast period owing to the factors such as rapidly developing economies, growing disposable income, and high adaption of the advanced delivery systems
- A few of the major market players in drug delivery systems space are F. Hoffmann-La Roche Ltd, Pfizer, Inc., Johnson and Johnson private Ltd, Novartis AG, Becton, Dickinson and Company, and Bayer AG.
- Major market players in the gene delivery systems space are SiBiono GeneTech Co., Unique N.V., Epeius Biotechnologies Corporation, Human Stem Cells Institute, and Shanghai Sunway Biotech Co., Ltd.
Browse related reports by Grand View Research:
Grand View Research has segmented the drug and gene delivery systems market on the basis of route of administration, vectors, methods, and region:
- Route of Administration Outlook (Revenue, USD Billion, 2014 - 2025)
- Oral
- Inhalation
- Transdermal
- Injectable
- Ocular
- Nasal
- Topical
- Vector Outlook (Revenue, USD Million, 2014 - 2025)
- Method Outlook (Revenue, USD Million, 2014 - 2025)
- Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S. Drug Delivery Systems Market, by Route of Administration
- U.S. Gene Delivery Systems Market, by Vectors
- U.S. Gene Delivery Systems Market, by Method
- Canada Drug Delivery Systems Market, by Route of Administration
- Canada Gene Delivery Systems Market, by Vectors
- Canada Gene Delivery Systems Market, by Method
- Europe
- UK Drug Delivery Systems Market, by Route of Administration
- UK Gene Delivery Systems Market, by Vectors
- UK Gene Delivery Systems Market, by Method
- Germany Drug Delivery Systems Market, by Route of Administration
- Germany Gene Delivery Systems Market, by Vectors
- Germany Gene Delivery Systems Market, by Method
- Asia Pacific
- Japan Drug Delivery Systems Market, by Route of Administration
- Japan Gene Delivery Systems Market, by Vectors
- Japan Gene Delivery Systems Market, by Method
- China Drug Delivery Systems Market, by Route of Administration
- China Gene Delivery Systems Market, by Vectors
- China Gene Delivery Systems Market, by Method
- Latin America
- Brazil Drug Delivery Systems Market, by Route of Administration
- Brazil Gene Delivery Systems Market, by Vectors
- Brazil Gene Delivery Systems Market, by Method
- Mexico Drug Delivery Systems Market, by Route of Administration
- Mexico Gene Delivery Systems Market, by Vectors
- Mexico Gene Delivery Systems Market, by Method
- MEA
- South Africa Drug Delivery Systems Market, by Route of Administration
- South Africa Gene Delivery Systems Market, by Vectors
- South Africa Gene Delivery Systems Market, by Method
Read Our Blog - http://www.grandviewresearch.com/blog/drug-gene-delivery-systems-market-size-share
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com
Share this article